AU7381901A - Method for analyzing soluble fibrin - Google Patents

Method for analyzing soluble fibrin

Info

Publication number
AU7381901A
AU7381901A AU73819/01A AU7381901A AU7381901A AU 7381901 A AU7381901 A AU 7381901A AU 73819/01 A AU73819/01 A AU 73819/01A AU 7381901 A AU7381901 A AU 7381901A AU 7381901 A AU7381901 A AU 7381901A
Authority
AU
Australia
Prior art keywords
soluble fibrin
analyzing soluble
analyzing
fibrin
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73819/01A
Inventor
Roland Hansen
Michael Praus
Wolf-Dieter Schleuning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7381901A publication Critical patent/AU7381901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/968—Plasmin, i.e. fibrinolysin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU73819/01A 2000-03-27 2001-03-27 Method for analyzing soluble fibrin Abandoned AU7381901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10016139 2000-03-27
DE2000116139 DE10016139A1 (en) 2000-03-27 2000-03-27 Method for the determination of soluble fibrin
PCT/DE2001/001207 WO2001073445A2 (en) 2000-03-27 2001-03-27 Method for analyzing soluble fibrin

Publications (1)

Publication Number Publication Date
AU7381901A true AU7381901A (en) 2001-10-08

Family

ID=7637178

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73819/01A Abandoned AU7381901A (en) 2000-03-27 2001-03-27 Method for analyzing soluble fibrin

Country Status (3)

Country Link
AU (1) AU7381901A (en)
DE (1) DE10016139A1 (en)
WO (1) WO2001073445A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3430906A1 (en) * 1984-08-22 1986-02-27 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR DETERMINING FIBRINE MONOMER IN PLASMA
SE8702556D0 (en) * 1987-06-18 1987-06-18 Kabivitrum Ab DETERMINATION OF PROTEOLYS ACTIVE COMPONENTS
US5114845A (en) * 1987-07-06 1992-05-19 Biopool International, Inc. Assays for plasminogen activator inhibitor and soluble fibrin
US6008019A (en) * 1989-02-13 1999-12-28 Schering Aktiengesellschaft Plasminogen activator from saliva of the vampire bat
CA2046632C (en) * 1989-02-13 1999-05-11 Berthold Baldus Thrombolytic from vampire bat saliva
DE3904580A1 (en) * 1989-02-13 1990-08-16 Schering Ag Thrombolytic agent

Also Published As

Publication number Publication date
WO2001073445A3 (en) 2002-05-10
DE10016139A1 (en) 2001-10-18
WO2001073445A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU2651701A (en) Method for introducing additives
AU2002363798A1 (en) Method for effecting hemostasis
AU2001263887A1 (en) Monitoring method
AU2002224154A1 (en) Method for producing polybutene
AU2002220898A1 (en) Ligand detection method
AU2002216080A1 (en) Method for determining competing risks
AU2001281633A1 (en) Detection method
AU2001267978A1 (en) Method for analyzing words
AU2308900A (en) Analysis method
AU2002221740A1 (en) Method for analyzing proteins
AUPQ667800A0 (en) Detection method
AUPR050700A0 (en) Detection method
AU5867901A (en) Method for detecting tumors
AU2001263751A1 (en) Rotating method
AU5650401A (en) Method for enhancing cognitive function
AU2001237530A1 (en) Method
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
AU2001241636A1 (en) Halotherapy method
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001259161A1 (en) Method for making polyimide
AU7381901A (en) Method for analyzing soluble fibrin
AU2001267403A1 (en) Method for examining macromolecules
AU2001265863A1 (en) Method for analyzing substance mixtures
AU6138500A (en) Method for measuring loss
AU2001232231A1 (en) Method for detecting substance

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase